Calciphylaxis in chronic kidney disease: a systematic review of pathomechanisms and risk factors for calcific uremic arteriolopathy.
Cecilie Søndergaard, Subagini Nagarajah, Jianlin Shen et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review examined the pathomechanisms and risk factors associated with calcific uremic arteriolopathy (CUA) in patients with chronic kidney disease (CKD). Out of 2374 publications screened, 35 studies were included. Key risk factors identified include decreased albumin, higher alkaline phosphatase, diabetes, and increased calcium phosphate product. The review highlights the need for further research to clarify the mechanisms underlying CUA.
Key findings
- Decreased albumin and higher alkaline phosphatase levels were consistently linked to CUA.
- Diabetes and increased body mass index were identified as significant risk factors.
- Vitamin K antagonist use was associated with a higher risk of developing CUA.
- Ambiguous findings were noted regarding matrix Gla protein alterations and hypercoagulability.
Why it matters
Understanding the risk factors and mechanisms of CUA is crucial for clinicians managing patients with CKD, as it may lead to improved early detection and prevention strategies for this serious condition.